Induction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells

Georgette L. Suidan, Jeremiah R. Mcdole, Yi Chen et al. · 2008

Read Induction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells by Georgette L. Suidan, Jeremiah R. Mcdole, Yi Chen et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003037.txt.

Introduction

Georgette Suidan, Jeremiah McDole, Yi Chen and co-authors showed CD8 T cells altering blood-brain barrier proteins in 2008. Barrier disruption marks immune brain disorders as varied as viral hemorrhagic fevers, cerebral malaria, and acute hemorrhagic leukoencephalitis. Models had proposed that immune cells promote vessel permeability in these diseases.

The team reports CD8 T cells induce changes in tight junction proteins, the seals between vessel cells. Published in PLOS ONE, that gives a direct mechanism for barrier opening. It identifies the seal proteins as points where protective treatment might act. Its full text, with tables and references, is openly available to any reader online.

Catalog record

CREATORGeorgette L. Suidan, Jeremiah R. Mcdole, Yi Chen et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003037

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Induction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells Authors: Georgette L. Suidan, Jeremiah R. Mcdole, Yi Chen, Istvan Pirko, Aaron J. Johnson Published: 2008, PLOS ONE DOI: 10.1371/journal.pone.0003037 ABSTRACT Disruption of the blood brain barrier (BBB) is a hallmark feature of immune-mediated neurological disorders as diverse as viral hemorrhagic fevers, cerebral malaria and acute hemorrhagic leukoencephalitis. Although current models hypothesize that immune cells promote vascular permeability in human disease, the role CD8 T cells play in BBB breakdown remains poorly defined. Our laboratory has developed a novel murine model of CD8 T cell mediated central nervous system (CNS) vascular permeability using a variation of the Theiler's virus model of multiple sclerosis. In previous studies, we observed that MHC class II −/− (CD4 T cell deficient), IFN-γR −/− , TNF-α −/− , TNFR1 −/− , TNFR2 −/− , and TNFR1/TNFR2 double knockout mice as well as those with inhibition of IL-1 and LTβ activity were susceptible to CNS vascular permeability. Therefore, the objective of this study was to determine the extent immune effector proteins utilized by CD8 T cells, perforin and FasL, contributed to CNS vascular permeability. Using techniques such as fluorescent activated cell sorting (FACS), T1 gadolinium-enhanced magnetic resonance imaging (MRI), FITC-albumin leakage assays, microvessel isolation, western blotting and immunofluorescent microscopy, we show that in vivo stimulation of CNS infiltrating antigen-specific CD8 T cells initiates astrocyte activation, alteration of BBB tight junction proteins and increased CNS vascular permeability in a non-apoptotic manner. Using the aforementioned techniques, we found that despite having similar expansion of CD8 T cells in the brain as wildtype and Fas Ligand deficient animals, perforin deficient mice were resistant to tight junction alterations and CNS vascular permeability. To our knowledge, this study is the first to demonstrate that CNS infiltrating antigen-specific CD8 T cells have the capacity to initiate BBB tight junction disruption through a non-apoptotic perforin dependent mechanism and our model is one of few that are useful for studies in this field. These novel findings are highly relevant to the development of therapies designed to control immune mediated CNS vascular permeability. INTRODUCTION Disruption of the BBB is a hallmark feature of immune-mediated neurological disorders as diverse as viral hemorrhagic fevers, cerebral malaria and acute hemorrhagic leukoencephalitis [1] – [6] . While immune-mediated CNS vascular permeability is a likely contributor to pathology in neurologic disease, the role of CD8 T cells in BBB breakdown under inflammatory conditions remains largely undefined. Studies using EM have determined that the healthy, intact neurovascular unit (NVU) consists of cerebral endothelial cells (CECs), basal lamina, astrocytic endfoot processes, pericytes and neurons [7] . Among these cell types, pericytes and astrocytes have the most direct interaction with vasculature. Astrocytic endfeet are in contact with 90% of abluminal CECs [4] , [8] . In vitro and in vivo studies support a role for astrocytes in controlling BBB maintenance and regulation through their interaction with CECs [9] – [13] . CEC tight junctions are composed of transmembranous proteins including occludin, claudin-5 and the cytoplasmic proteins zona occludens 1, 2 and 3 (ZO-1, ZO-2, ZO-3) [3] . Consistent with in vitro models, CNS vascular permeability coincides with alteration of CEC tight junctions in rodent models of BBB breakdown [3] , [14] – [16] . Although current models hypothesize that immune cells promote opening of the BBB in human disease, the role of CNS infiltrating antigen specific CD8 T cells in initiating vascular permeability has not been determined. Expansion and global activation of CD8 T cells has been observed in cases of viral hemorrhagic fever, suggesting that these cells may play an important role in vascular permeability [17] – [19] . To study the interaction between CD8 T cells and the NVU under neuro-inflammatory conditions, our laboratory has developed a novel mouse model of CNS vascular permeability using a variation of the Theiler's murine encephalomyelitis virus (TMEV) model commonly used to study multiple sclerosis [20] – [22] . Seven days post TMEV infection, there is a massive expansion of CNS infiltrating CD8 T cells specific for a 10 amino acid TMEV peptide, VP2 121–130 , presented in the context of the D b class I molecule [23] , [24] . Intravenous administration of 0.1 mg of VP2 121–130 peptide seven days post infection results in severe CNS vascular permeability in C57BL/6 mice, leading to mortality within 48 hours [20] . In previous studies, we observed that major histocompatibility complex (MHC) class II −/− (CD4 T cell deficient), IFN-γR −/− , TNF-α −/− , TNFR1 −/− , TNFR2 −/− , and TNFR1/TNFR2 double knockout mice were susceptible to this fatal syndrome. We also determined that inhibition of interleukin-1 and lymphotoxin-β activity did not protect mice from becoming moribund. In contrast, perforin deficient mice did not become moribund in this system [20] . These data indicated that obvious candidate cytokines as well as CD4 T cell responses were not necessary for the development of this fatal syndrome. Therefore, the objective of this study was to determine the extent immune effector proteins utilized by CD8 T cells, perforin and FasL, contributed to CNS vascular permeability and the resultant fatal syndrome. In this paper, we present evidence that antigen specific CD8 T cells have the capacity to initiate changes to the NVU as measured by astrocyte activation and alteration of CEC tight junction proteins. Our findings confirm that CD8 T cells specific for the D b :VP2 121–130 epitope initiate CNS vascular permeability and morbidity in C57BL/6 mice. Furthermore, we have determined that this process is perforin dependent. RESULTS To assess the CD8 T cell response of immune effector protein deficient mice during acute TMEV infection, we performed flow-cytometric analysis of lymphocytes isolated from the brain. Isolated CNS infiltrating lymphocytes from 7 day TMEV infected C57BL/6 (n = 4), C57BL/6 Prf1 −/− (n = 4) and C57BL/6 FasL −/− (n = 4) mice were stained with antibody to CD8, CD44 and D b :VP2 121–130 tetramer or irrelevant D b :E7 tetramer control. Using D b :VP2 121–130 tetramer staining, we determined that in the brains of C57BL/6, C57BL/6 Prf1 −/− and C57BL/6 FasL −/− mice, approximately 50–70% of CD44+ CD8+ T cells were specific for the D b :VP2 121–130 epitope regardless of strain genotype ( Figure 1A–C ). Irrelevant D b :E7 tetramer did not appreciably stain CD8 T cells ( Figure 1D ) [23] . We did not observe overt differences in the number of isolated immune cells or frequencies of CD8+ cells among the three genotypes (data not shown). These results demonstrated that the expansion of CNS infiltrating D b :VP2 121–130 epitope specific CD8 T cells was not markedly different between C57BL/6, C57BL/6 Prf1 −/− and C57BL/6 FasL −/− mice post TMEV infection. Shown are brain infiltrating CD8+ cells isolated from (A) C57BL/6 mice, (B) C57BL/6 Prf1 −/− mice and (C) C57BL/6 FasL −/− mice were gated and analyzed for CD44 activation marker expression and D b :VP2 121–130 tetramer staining. In (D), C57BL/6 CD8+ cells were stained with negative control D b :E7 tetramer and anti-CD44. Upper gates denote percentage of CD44+ cells that stain with D b :VP2 121–130 or D b :E7 tetramer. VASCULAR PERMEABILITY IS DEPENDENT

Read the complete text